Showing results (321-330 of 342) with videos related to

Sort By:
Pageof 35
NPJ Precision Oncology|March 14, 2025
Lethal co-expression intolerance underlies the mutually exclusive expression of ASCL1 and NEUROD1 in SCLC cellsHirofumi Watanabe, Yusuke Inoue, Kazuo Tsuchiya, et al.
BMC Pulmonary Medicine|October 8, 2024
Risk factors for relapse of immune-related pneumonitis after 6-week oral prednisolone therapy: a follow-up analysis of a phase II studyMasato Karayama, Naoki Inui, Yusuke Inoue, et al.
Angewandte Chemie (International Ed. in English)|February 16, 2024
Anionic Sublattices in Halide Solid Electrolytes: A Case Study with the High-Pressure Phase of Li3ScCl6Fenghua Ding, Atsunori Doi, Takafumi Ogawa, et al.
Journal for Immunotherapy of Cancer|July 27, 2023
Six-week oral prednisolone therapy for immune-related pneumonitis: a single-arm phase II studyMasato Karayama, Naoki Inui, Yusuke Inoue, et al.
Respiratory Medicine|November 28, 2017
Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: A retrospective multicenter studyYasunori Enomoto, Yutaro Nakamura, Yasuomi Satake, et al.
JTO Clinical and Research Reports|July 4, 2025
Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort StudiesYusuke Inoue, Yoshihiro Kitahara, Masato Karayama, et al.
Cancer Immunology, Immunotherapy : CII|June 6, 2021
Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancerMasato Karayama, Naoki Inui, Yusuke Inoue, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 17, 2024
The emerging emetogenicity of trifluridine/tipiracil (TAS‑102) from patient self-reporting: a multicenter, prospective, observational studyHironori Fujii, Masami Tsuchiya, Daichi Watanabe, et al.
Journal of Clinical Medicine|April 30, 2021
Prognostic and Clinical Value of Cluster Analysis in Idiopathic Pleuroparenchymal Fibroelastosis PhenotypesYutaro Nakamura, Kazutaka Mori, Yasunori Enomoto, et al.
JAMA Network Open|September 21, 2020
Evaluation of Programmed Death Ligand 1 (PD-L1) Gene Amplification and Response to Nivolumab Monotherapy in Non-small Cell Lung CancerYusuke Inoue, Katsuhiro Yoshimura, Koji Nishimoto, et al.
Pageof 35